Infection Control

Oncologists express concern about infections in cancer patients

Infection Control Weekly Monitor, June 3, 2009

Want to receive articles like this one in your inbox? Subscribe to Infection Control Weekly Monitor!

On May 27, a survey released by Amgen revealed that 92% of oncologists believe it’s important to prevent infections in cancer patients in order to achieve successful outcomes. Still, 96% of infectious disease specialists, and 79% of oncologists reported an increase in antibiotic resistant infections in cancer patients over the past five years, according to a press release.

Both professionals said MRSA was most common in chemotherapy patients, who are at higher risk for infection because they suffer from a compromised immune system. As a result, Amgen is partnering with the CDC and the Divisions of Healthcare Quality and Promotion and Cancer Prevention and Control at the CDC, on a three-year initiative that will provide resources and tools to help both healthcare workers and patients.



Want to receive articles like this one in your inbox? Subscribe to Infection Control Weekly Monitor!

Most Popular

Related Articles